DANCR通过调节DANCR-MLL3轴促进胰腺癌进展的机制

刘阳 ,  梁雷 ,  张波 ,  毕研玲 ,  张猛

中国现代普通外科进展 ›› 2026, Vol. 29 ›› Issue (3) : 174 -180.

PDF (7591KB)
中国现代普通外科进展 ›› 2026, Vol. 29 ›› Issue (3) : 174 -180. DOI: 10.3969/j.issn.1009-9905.2026.03.002
论著

DANCR通过调节DANCR-MLL3轴促进胰腺癌进展的机制

作者信息 +

Mechanism of DANCR in promoting pancreatic cancer progression via modulation of DANCR-MLL3 axis

Author information +
文章历史 +
PDF (7772K)

摘要

目的:探究长链非编码RNA分化拮抗非蛋白编码RNA(DANCR)及通过调控DANCR-混合谱系白血病3(MLL3)轴影响胰腺癌进展的分子机制。方法:收集泰安市中心医院2019年1月—2022年12月收治的120例胰腺癌患者的肿瘤组织及配对癌旁组织,检测DANCR表达量,分析其与临床病理参数及预后的关联;在胰腺癌细胞系(MIA PaCa-2、PANC-1)中敲低DANCR,通过CCK-8、划痕实验、Transwell实验评估其对细胞增殖、迁移及侵袭能力的影响。采用双荧光素酶报告基因实验验证DANCR对MLL3启动子活性的调控作用。通过蛋白质印迹法检测MLL3、H3K4me3及p57的蛋白表达,并使用MLL3抑制剂MI-503进行回复实验,验证DANCR-MLL3-p57信号轴的功能。结果:胰腺癌组织中DANCR mRNA表达显著高于癌旁组织(P<0.01);胰腺癌细胞系中DANCR mRNA表达显著高于正常胰腺导管上皮细胞(P<0.01),MLL3 mRNA表达则显著降低(P<0.01),且胰腺癌细胞系中两者表达呈显著负相关(r=-0.808,P<0.01);DANCR高表达与胰腺癌淋巴结转移、低分化相关(P<0.01),且高表达患者总生存期显著缩短(P<0.01);敲低DANCR后,MIA PaCa-2、PANC-1细胞增殖活力、划痕迁移率、Transwell迁移及侵袭细胞数均显著降低(P<0.01);双荧光素酶报告基因实验证实DANCR可抑制MLL3启动子活性(P<0.01);敲低DANCR可上调MLL3、H3K4me3、p57蛋白表达(P<0.01),而加入MI-503可逆转上述蛋白表达变化及细胞功能抑制效应(P<0.01)。结论:DANCR通过调节DANCR-MLL3轴促进胰腺癌的恶性进展,可能成为胰腺癌潜在的预后生物标志物和治疗靶点。

Abstract

Objective: To investigate the molecular mechanism by which the long non-coding RNA Differentiation Antagonizing Non-protein Coding RNA (DANCR) influences pancreatic cancer progression via regulating the DANCR-Mixed Lineage Leukemia 3 (MLL3) axis. Methods: Tumor tissues and paired adjacent normal tissues were collected from 120 pancreatic cancer patients admitted to Tai'an Central Hospital from January 2019 to December 2022. DANCR expression levels were detected and analyzed for their association with clinicopathological parameters and patient prognosis. DANCR was knocked down in pancreatic cancer cell lines (MIA PaCa-2, PANC-1). The effects on cell proliferation, migration, and invasion were assessed using CCK-8 assay, scratch wound healing assay, and Transwell assay. The regulatory effect of DANCR on MLL3 promoter activity was validated through a dual luciferase reporter gene assay. Protein expression levels of MLL3, H3K4me3, and p57 were detected by Western blotting. Rescue experiments were performed using the MLL3 inhibitor MI-503 to validate the function of the DANCR-MLL3-p57 signaling axis. Results: DANCR expression was significantly higher in pancreatic cancer tissues compared to adjacent normal tissues (P<0.01). Consistently, its expression was upregulated in pancreatic cancer cell lines compared to normal pancreatic ductal epithelial cells (P<0.01), while MLL3 expression was significantly reduced (P<0.01), showing a significant negative correlation (r=-0.808, P<0.01). High DANCR expression was associated with lymph node metastasis and poor differentiation in pancreatic cancer patients (P<0.01), and patients with high expression had a significantly shorter overall survival (P<0.01). Knockdown of DANCR significantly reduced proliferation viability, scratch wound healing rate, and the number of migrating and invading cells in both MIA PaCa-2 and PANC-1 cells (P<0.01). Dual-luciferase reporter gene experiments confirmed that DANCR inhibits MLL3 promoter activity (P<0.01). DANCR knockdown upregulated the protein expression levels of MLL3, H3K4me3, and p57 (P<0.01). The addition of MI-503 reversed these protein expression changes and the inhibitory effects on cell function (P<0.01). Conclusion: DANCR promotes the malignant progression of pancreatic cancer by regulating the DANCR-MLL3 axis, suggesting its potential as a prognostic biomarker and therapeutic target for pancreatic cancer.

关键词

胰腺肿瘤 / 分化拮抗非蛋白编码RNA / 混合谱系白血病3 / 增殖 / 侵袭

Key words

Pancreatic neoplasms / Differentiation antagonizing non-protein coding RNA / Mixed lineage leukemia 3 / Proliferation / Invasion

引用本文

引用格式 ▾
刘阳,梁雷,张波,毕研玲,张猛. DANCR通过调节DANCR-MLL3轴促进胰腺癌进展的机制[J]. 中国现代普通外科进展, 2026, 29(3): 174-180 DOI:10.3969/j.issn.1009-9905.2026.03.002

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Wang S , Feng W , Wang W , et al. Girdin knockdown increases gemcitabine chemosensitivity to pancreatic cancer by modulating autophagy[J]. Front Oncol, 2021, 11: 618764. DOI: 10.3389/fonc.2021.618764.

[2]

徐衍杰, 吴仰东, 王强, . 基于免疫相关基因的胰腺癌预后模型构建及其在免疫微环境中的应用[J]. 中国现代普通外科进展202528(7): 530-537. DOI: 10.3969/j.issn.1009—9905.2025.07.005.

[3]

Stoop TF , Javed AA , Oba A , et al. Pancreatic cancer[J]. Lancet, 2025, 405(10485): 1182-1202. DOI: 10.1016/s0140—6736(25)00261—2.

[4]

Beteta—Göbel R , Miralles M , Fernández—Díaz J , et al. HCA (2—Hydroxy—Docosahexaenoic Acid) induces apoptosis and endoplasmic reticulum stress in pancreatic cancer cells[J]. Int J Mol Sci, 2022, 23(17): 9902. DOI: 10.3390/ijms23179902.

[5]

Tang B , Wang L , Wei D , et al. METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A—dependent alternative splicing in PANC—1 cells[J]. Discov Oncol, 2025, 16(1): 1590. DOI: 10.1007/s12672—025—03393—3.

[6]

Baek M , Kim M , Choi HI , et al. Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib—treated sorafenib—resistant Huh7 hepatocellular carcinoma cells[J]. PLoS One, 2024, 19(4): e0301663. DOI: 10.1371/journal.pone.0301663.

[7]

王剑, 马松林, 周婷婷, . 长链非编码RNA SNHG16在胰腺癌中的表达及功能[J]. 华中科技大学学报(医学版)202049(1): 11-16. DOI: 10.3870/j.issn.1672—0741.2020.01.003.

[8]

Shin CH , Kim K , Ho CW , et al. Long noncoding RNAs regulating enzymatic reactions in cancer[J]. Exp Mol Med, 2025, 57(8): 1641-1650. DOI: 10.1038/s12276—025—01464—7.

[9]

Wang Q , Li XF , Zhou YH , et al. Long noncoding RNA BBOX1—AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1[J]. Transl Oncol, 2023, 36: 101751. DOI: 10.1016/j.tranon.2023.101751.

[10]

Yi YC , Chen XY , Zhang J , et al. Novel insights into the interplay between m(6)A modification and noncoding RNAs in cancer[J]. Mol Cancer, 2020, 19(1): 121. DOI: 10.1186/s12943—020—01233—2.

[11]

Rojas A , Sepulveda H , Henriquez B , et al. Mll—COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts[J]. J Cell Physiol, 2019, 234(5): 6244-6253. DOI: 10.1002/jcp.27355.

[12]

付晓伟, 欧阳永灏, 洪乐, . 基于高通量测序技术的胰腺癌环状RNA差异表达谱分析[J]. 安徽医科大学学报202358(01): 101-108. DOI: 10.19405/j.cnki.issn1000—1492.2023.01.017.

[13]

Liu W , Wang QP , Guo J . Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta—analysis[J]. Biosci Rep, 2021, 41(8): BSR20181627. DOI: 10.1042/BSR20181627.

[14]

Gan X , Ding D , Wang M , et al. DANCR deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient—derived xenograft in situ hepatoma mice model[J]. Cancer Lett, 2022, 550: 215930. DOI: 10.1016/j.canlet.2022.215930.

[15]

Zhang KJ , Tan XL , Guo L . The long non—coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2—dependent suppression of SOCS3 transcription[J]. Mol Oncol, 2020, 14(2): 309-328. DOI: 10.1002/1878—0261.12622.

[16]

成洪杰, 张晓, 崔培林 . 长链非编码RNA HOTAIR对胰腺癌细胞增殖、迁移能力的影响[J]. 胃肠病学和肝病学杂志202231(2): 219-224. DOI: 10.3969/j.issn.1006—5709.2022.02.019.

[17]

Kim NY , Jung YY , Um JY , et al. Cannabidiol suppresses EMT in pancreatic cancer via inhibition of MALAT1 lncRNA and PI3K/Akt/mTOR signaling pathway[J]. IUBMB Life, 2025, 77(8): e70042. DOI: 10.1002/iub.70042.

[18]

Fan W , Xu Z , Liang S , et al. MLL3 inhibits apoptosis of rheumatoid arthritis fibroblast—like synoviocytes and promotes secretion of inflammatory factors by activating CCL2 and the NF—kappaB pathway[J]. Inflammation, 2021, 44(5): 1803-1814. DOI: 10.1007/s10753—021—01459—2.

[19]

Yue H , Na YL , Feng XL , et al. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer[J]. World J Gastroenterol, 2003, 9(2): 377-380. DOI: 10.3748/wjg.v9.i2.377.

基金资助

泰安市科技创新发展项目(2023NS271)

AI Summary AI Mindmap
PDF (7591KB)

119

访问

0

被引

详细

导航
相关文章

AI思维导图

/